The company presentation dated 4/10/2016 shows cash on hand as $38.2 Million as of 2/29/2016. They have a $40 million credit line with LPC. There are warrants that can be exercised if needed. NOTHING is going to happen before the Neuvax interim data is released. Once Galena Bio gets the "Go to Completion" on Neuvax partnership $$$ will be on the table. Forget your silly imminent dilution blathering.
Untapped $40 million credit line w LPC is FACT not speculative.
I have been wondering the same about BP influence w all of this shorting.
Complete Trash, you have "swing trader" in your name! Yet you claim that the "Real problem is the extreme pumpers who are usually SWING TRADERS who pump and dump" LOL. You also just created this latest "brianswingtrader" Yahoo ID a few hours ago. Wow, you have already discredited your latest ID, time to create yet another one.
Dr Mittendorf's article came out rather late in the day. Perhaps a positive impact will come Wed/Thur.
This thread is filled with nonsense presented by Galena Bio Shorts. For those seeking honest analysis check out the rocketjock1 and apollo1452 posts.
Impressive analysis Apollo, who says YMB doesn't have quality posts? You illustrate very clearly the shorts predicament.
Dr Joe as Dan calls him stated that he is a Galena Bio shareholder and overall he was bullish imo. He obviously is very intelligent, well spoken and knows a great deal. I enjoyed listening to his comments. However, he was fair in admitting that there's a lot he doesn't know since he's been out of the Galena loop for several years.
Everyone seemed to be interested in hearing Dr Joe's comments on the Neuvax interim analysis. His comments were cautious and he listed all of the possibilities. He very much doubts the trial would be stopped for futility. As he was speaking about the interim analysis it almost seemed as though he was reading from a FDA text. At this point I was thinking in my own mind that Dr Joe isn't up to speed on what clues Galena actually has about the Nuevax data. The authority on the interim analysis remains Galena's own Dr Bijan Nejadnik. Afterall, that's what Bijan was hired for. The best clues to what lies ahead for Galena are in Bijan's comments and the stat analysis of Dr David Fujii imho.
What CC were you listening to kramer, or did you forget to turn up your hearing aid?
You may be competing for shares with tutes by then, the demise of the delisting bogeyman is official at 4pm Tues
That's why I decided to jump in, it was the de-risking event that I was waiting for.
True, multiple reasons that could be turbocharging today's pps rise. Even with a cursory glance at Galena dd this stock looks like a strong buy to me. This is still the infant stage compared to the massive potential.
Sentiment: Strong Buy
Today Adam F has been totally marginalized, he is now a non-factor in the Galena Bio story.
Sentiment: Strong Buy